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SENSITIZATION OF GUINEA PIGS TO CHROMIUM SALTS*
PAUL R. GROSS, M.D.t SIDNEY A. KATZ, Pn.D. AND M. H. SAMITZ, M.D.
Allergic contact dermatitis to chromates has
been recognized for many years. Recently cross-
reactions between hexavalent and trivalent chro-
mium salts have been reported. Several ques-
tions remain unanswered. Why is hexavalent
chromium more immunologically active? Do
percutaneous absorption rates account for all
the clinical differences observed? What is the
importance of the carrier-protein? Recently, we
have sought these answers employing guinea
pigs as an experimental model.
As a preliminary step in the study of reac-
tions of guinea pigs to chromium-protein com-
plexes, attempts were made to sensitize the ani-
mals to potassium dichromate and chromic
chloride. When the techniques of Hunziker (1)
and Van Neer (2) were employed, the results
were inconsistent and disappointing. The rate
of successful sensitization, as determined by de-
layed papular reactions to intradermal tests,
never exceeded 20%. Therefore, we reevaluated
and modified the procedures, until after several
trials our techniques gave consistently successful
results. The details are presented along with
other pertinent information regarding cross-
reactivity of several chromium salts.
rnocxouan
Albino guinea pigs weighing 300 and 500 Gm.
were sensitized to hexavalent chromium (K,Cr,O,)
by three subcutaneous injections in the nape one
week apart. The following emulsion was injected:
0.5 cc Freund's complete adjuvant (Difco) with
0.5 cc of 3.4 X 10 M of K,Cr207 .t Three weeks
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t A concentration 3.4 X 10 M is equivalent to
0.1% solution (W/V) of K,Cr,O7, each 0.5 cc con-
taining 0.5 mg of the salt; so that each guinea pig
receives a total of 1.5 mg of K,Cr,07. This repre-
sents the reference concentration for serial dilu-
later the animals were tested with intradermal in-
jections in clipped or epilated skin. The eliciting
dose was 0.1 cc of 4.2 >< 10 M K2Cr2O7 in phys-
iologic saline. This produced, at 48 hours, a well-
defined indurated erythematous papule, at least
10 mm in diameter. In control animals no reaction
was present at 48 hours. Weaker reactions were
usually obtained with test concentrations of 2.1 X
l0 M; below this level results were inconsistent.
With the same procedure, guinea pigs were sen-
sitized to chromic chloride; the sensitizing injec-
tions contained 0.5 cc of Freund's complete adju-
vant with 0.5 cc of 3.4 >< 10 M CrCb. The test
dose was 0.1 cc of 4.2 >< 10 M CrC15 in physiologic
saline intradermally. This produced no reaction
whatsoever in thirty control animals.
Having established delayed hypersensitivity to
hexavalent and trivalent chromium compounds,
several sets of experiments relative to cross-reac-
tions were performed. Animals sensitized with
K,Cr,O7 or CrC1, were tested with both compounds
and a number of additional trivalent salts. More-
over, they were also exposed to conjugates of
chromium linked with plasma proteins and skin
extract proteins (modification of the technique of
Salvin and Smith) (4, 5).
REsULTs
Initial sensitizotion: After the above sensiti-
zation to K,Cr2O,, twenty-six of twenty-seven
previously unexposed guinea pigs developed pos-
itive skin tests to K2Cr5O, . In all cases the 48
hour intradermal skin test result was an in-
durated erythematous papulc of at least 10 mm
(+1 response). In twenty-three of the animals
the response measured over 15 mm (+2); in
twelve the response was greater than 20 mm
(+3); and in two, central necrosis developed in
the reaction (+4).
When CrCl, was used for sensitization, ten of
tions. We are in complete agreement with Epstein(3), who has stressed the importance of express-
ing concentrations in molarity rather than weight!
volume as this usage allows for immediate, accu-
rate comparison of the actual quantity of the Cr
ion in solutions of different Cr salts, e.g.:
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Molarity K,Cr,O, CrCI3.(W/V) 611,0
3.4 X i0—
8.5 X 10—4
4.2 X 10—4
2.3 x 10—'
0.10%
0.025%
0.Oii%
0. 008%
0. 090%
0.021%
0. 011%
0.008%
Cn(S04),.
1511,0
0. 19%
0. 048%
0. 024%
0.012%
Cr(NO,),.
911,0
0.14%
0. 034%
0. 017%
0.008%
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thirteen animals developed positive reactions (at
least +) ; of these, four were read as (+2).
None developed (+3) or (+4) reactions.
Cross-reactions: Of the twenty-six guinea pigs
sensitized to K,Cr207 (Cr1), all reacted to CrC13
(Cr111) (see Table I). In most cases the reac-
tion to Cry5 was of greater magnitude, but in
seven animals the degree of reactivity was the
same and in one there was a greater reaction to
Cr111 than to Cr1 . The difference in reactivity
to Cr1 and Cr115 is significant at P= 0.005, em-
ploying the Wilcoxon matched pairs, signed-rank
test (6).
TABLE I
Skin test reactions to potassium dichromate and
chromic chloride in guinea pigs sensitized to
potassium dichromate (see text for techniques)
* Note: (—) = no response; (±) = equivocal
response, less than 10 mm diameter; (+1) =
response of 10 mm diameter; (+2) = response of
15mm diameter; (+3) response of 20 mm diam-
eter; (+4) response of 20 mm diameter with
central necrosis.
Guinea pig no. Chromic chloride Potassiumdichromate
1 +1 +1
2 +2 +1
3 +1 +2
4 +1 +1
5 +1 +1
6 +2 +2
7 +1 —
8 +2 +1
9 +1 +1
10 +2 —
TABLE III
Skin test reactions to chromium salts in guinea pigs
which had been sensitized to potassium dichromate
(see text for concentrations employed)
Guinea
pig no.
Potas-
sium
dichro-
mate
Chro-
mc
acetate
Chromic
chloride
Chromic
nitrate
Chromic
sulfate
Chro-
mic
oxalate
1 +3 +2 +2 +3 +2
2 +3 +2 +2 +3 +3
3 +2 +2 +2 +2 +2 -
Of the ten guinea pigs sensitized to CrC11,
eight also reacted to K,Cr2O7 (see Table II). In
five cases the degree of reactivity was identical.
In one case there was a greater reaction to Cr1
than Cr111 . The differences in reactivity are not
statistically significant.
Reactions to other trivalent salts: Studies of
a similar nature were conducted with four other
solutions of trivalent chromium salts. The high-
est concentrations which were not irritating to
control animals were determined by serial dilu-
tion and subsequently used for skin testing. They
are as follows: Chromic acetate (2.5 X 10' M),
chromic nitrate (9.6 x 10), chromie oxalate
(2.5 >< 10-4M), chromic sulfate (2.4 X 10 M).
Three guinea pigs highly sensitive to K2Cr2O7
had significant cross-reactions to the acetate,
nitrate, chloride, and sulfate, but not the oxalate
salt (see Table III). Three animals sensitized to
CrCl3 showed weaker cross-reactions to the same
compounds (see Table IV).
Attempts to sensitize guinea pigs with the
TABLE II
Skin test reactions to potassium dichromate and
chromic chloride in guinea pigs sensitized to
chromic chloride
Guinea pig no.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Reaction to potas-
sium dichromate
*
+2
+1
+2
+1
+2
+2
+2
+2
+2
+3
+3
+3
+1
+3
+4
+3
+3
+2
+3
+2
+3
+2
+3
+3
+2
+3
Reaction to chromic
chloride
+2
+1
+1
+1
+2
+2
+2
+1
+1
+2
+2
+2
+2
+2
+2
+2
+2
+1
+1
+2
+1
+2
+2
+1
+1
+2
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TABLE IV
Skin test reactions to chromium salts in guinea pigs
which had been sensitized to chromic chloride
.Guinea
pig no.
Chro-
ma
chloride
Potas-
sium
dichro-
mate
Chromic
acetate
Chromic
nitrate
Chromic
sulfate
Chro-
mic
oxalate
1 +1 +1 - +1 +1
2 +2 +1 +1 +1 +1
3 +2 - +1 +2 +1 -
above trivalent salts, other than CrC15, were
uniformly unsuccessful. Concentrations of 1.7 x
102 M to 5 >< 10 M were used with Freund's
complete adjuvant in a schedule identical to that
which had been successfully used for K2Cr2O,
and CrCla.
Reoctions to chromium-protein conjugates:
It was not possible to sensitize guinea pigs to
conjugates of K2Cr2O7 with guinea pig serum
albumin, globulin, or guinea pig skin extract, by
using Freund's adjuvant and the above described
schedule. The experiments with CrCl,, conjugated
to the same proteins also failed to evoke sensi-
tivity to either the conjugate or the salt by it-
self. Similarly, when animals which were sensi-
tized to either K2Cr2O, or CrCl3 with Freund's
complete adjuvant, as described above, were
tested with chromium-protein conjugates (VI or
III), they failed to react, even though they
showed definite reactions to the simple uncon-
jugated salts. It should be emphasized that the
chromium content of these conjugates, as deter-
mined by tracer technique with labeled Cr51, was
in the same range as that of the simple solu-
tions to which the animals were highly reactive
(2.1 to 5.0 x 10' M).
DIscussIoN
The techniques described above for inducing
sensitization to chromium are reliable and rela-
tively simple. Though Hunziker's method (1) is
similar, these modifications have greatly in-
creased the success rate employing dichromate
and have, for the first time, allowed consistent
achievement of sensitivity in animals using a
trivalent salt. The sensitization is long lasting.
Animals which were followed for one year re-
tained their reactivity. Frequently the animals
developed ulceration at the site of injection of
the sensitizing emulsion but this invariably
healed in two to three weeks. This occurred with
both K2Cr2O7 and CrC13, unlike the typical
"chrome ulcers" seen clinically and experimen-
tally which are produced only by hexavalent
chromium (7). Control animals injected only
with Freund's complete adjuvant did not de-
velop local ulceration. The mechanism of this
reaction at the injection site probably represents
local irritation. Successful sensitization occurred
in many animals which did not develop ulcera-
tion.
Cross-reactivity between hexavalent and tri-
valent chromium salts has been demonstrated in
sensitized subjects (8, 9, 10). This has been
confirmed in guinea pigs by our present experi-
ments. Yet there can be little doubt that K2Cr2O7
is a more effective sensitizer, even when differ-
ences in percutaneous absorption are obviated
by use of intradermal injections. This has also
been the conclusion of Mali et ol. (11). The re-
actions to the hexavalent salt were consistently
greater in degree. Sensitization was achieved
with concentrations ten fold less than CrCI3
Moreover, animals sensitized to K2Cr2O7 showed
more cross-reactions, which may be interpreted
as an indication of a higher degree of sensitivity.
Similarly, Fregert and Rorsman (12) have
shown that the hexavalent chromium salts are
more effective elicitors after sensitization has
been established.
There are significant variations in the sensitiz-
ing and eliciting capacities of the several tri-
valent salts tested. The more highly dissociated
salts produced more reactions than weakly dis-
sociated salts. We have previously postulated
that differences in epicutaneous sensitivity were
due to differences in diffusion through the epi-
dermis and have confirmed this by diffusion rate
measurements in vitro (13). However, since this
route was by-passed in these studies, we are led
to the conclusion that the differences in reac-
tivity are also in part inherent in the specific
chromium salts. They are probably a function
of their degree of dissociation, though Fregert
and Rorsman (12) believe solubility in the phys-
iologic range of pH is the important factor. The
chromium ion itself undoubtedly is the hapten
responsible for sensitization. The clinical and ex-
perimental differences observed among various
chromium salts reflect the degree to which the
chromium ion is available (through absorption
and dissociation) to form a complete antigen by
conjugation with a suitable carrier protein. Ex-
periments quantitating the degree of binding to
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protein strongly suggest that the ion is in the
trivalent state when conjugation occurs (5).
Hexavalent chromium is reduced in vitro before
it is hound. It is possible that the redox reaction
with Cry, provides a protein carrier with stronger
affinity for binding or that the trivalent chro-
mium as might develop from the interaction is
predisposed to form a hapten-protein complex
with a linkage of greater relevancy or the same
hapten may become attached to two different
points on the same protein serving to define two
different antigenie determinations.
Benaeerraf and Cell (14) and Cell and Silver-
stein (15) have masterfully demonstrated that
in delayed allergy to simple chemicals there is
specificity to the carrier protein as well as the
hapten. For example, guinea pigs sensitized to
conjugates of pieryl and albumin are more re-
active to that conjugate than they are to a con-
jugate of picryl and globulin. We had hoped this
principle would apply to our work with conju-
gates of chromium and various proteins and
could determine what protein binds with chro-
mium in vivo to form the complete antigen. Un-
fortunately, tIns experiment was unsuccessful.
However, since in vitro studies (5) have indi-
cated that the chromium is bound to free amino
and free earboxyl groups on the protein mole-
cule, we are currently extending this work, using
conjugates of chromium to the synthetic poly-
peptides poly-1-lysine and poly-1-glutamie acid,
which should provide more information on car-
rier specificity.
sUMMAitv
Techniques are outlined for the consistent
production of delayed hypersensitivity to chro-
mium in guinea pigs. Cross-reactions among
various hexavalent and trivalent salts are read-
ily elicited when differences in percutaneous ab-
sorption are obviated. A theory of sensitization
to chromium is presented which we hope will
clarify the controversy over valeney and cx-
plain the differences observed clinically and ex-
perimentally.
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